Ibrance 100 mg (Palbociclib TABLET) 100 MG

IBRANCE 100 MG is a medication used in cancer treatment. This oral tablet, manufactured by Pfizer Canada ULC, contains palbociclib, a CDK4/6 inhibitor. Learn more about its uses and effects.

Strength

100 MG

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

IBRANCE 100 MG is primarily used in combination with other treatments for certain types of cancer. It is often prescribed for advanced or metastatic breast cancer in postmenopausal women. The medication works by inhibiting specific proteins that promote cancer cell growth. Patients should consult their healthcare provider to understand what is IBRANCE 100 MG used for in their specific case.

Side Effects

Common effects of IBRANCE 100 MG may include fatigue, nausea, and low blood cell counts. Some users might experience hair loss or infections. These effects can vary widely among individuals. It is important to discuss any persistent or severe symptoms with a healthcare professional.

Precautions & Warnings

IBRANCE 100 MG should be handled with care. It is essential to follow the prescribed dosage and administration instructions. Pregnant women or those planning to become pregnant should avoid this medication due to potential risks. Always store the tablets in a cool, dry place away from children.

Avoid Interactions

IBRANCE 100 MG may interact with certain medications, including strong CYP3A inhibitors and inducers. It is crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect the medication's efficacy.

Frequently Asked Questions

IBRANCE 100 MG is used in combination with other treatments for certain types of cancer, particularly advanced or metastatic breast cancer in postmenopausal women.

IBRANCE 100 MG is an oral tablet that should be taken as prescribed by a healthcare provider. It is important to follow the recommended dosage and administration instructions.

Common side effects may include fatigue, nausea, low blood cell counts, hair loss, and infections. Any persistent or severe symptoms should be discussed with a healthcare professional.

IBRANCE 100 MG may interact with certain medications, including strong CYP3A inhibitors and inducers. Always inform your healthcare provider about all medications you are taking.

IBRANCE 100 MG is not recommended for pregnant women due to potential risks. Women planning to become pregnant should consult their healthcare provider before taking this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.